Dextranomer/hyaluronic acid copolymer for the treatment of vesicoureteral reflux.
Ernst
Beth A
BA
D000283:Administration, Intravesical; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D002626:Chemistry, Pharmaceutical; D018890:Chemoprevention; D002648:Child; D003558:Cystoscopy / Q000379:methods* / Q000451:nursing; D003911:Dextrans / Q000737:chemistry / Q000494:pharmacology / Q000627:therapeutic use*; D006801:Humans; D006820:Hyaluronic Acid / Q000737:chemistry / Q000494:pharmacology / Q000627:therapeutic use*; D024802:Nurse's Role; D018579:Patient Selection; D012307:Risk Factors; D014481:United States; D014486:United States Food and Drug Administration; D014718:Vesico-Ureteral Reflux / Q000453:epidemiology / Q000628:therapy*
D000900:Anti-Bacterial Agents; D003911:Dextrans; C094535:deflux; D006820:Hyaluronic Acid